Location History:
- Hjarup, SE (2004)
- Hjärup, SE (2003 - 2015)
Company Filing History:
2 out of 3 
1 out of 2,104 
1 out of 9 
Years Active: 2003-2015
Title: The Innovations of Bengt E B Sandberg
Introduction
Bengt E B Sandberg is a notable inventor based in Hjärup, Sweden. He has made significant contributions to the field of biomolecular research, holding three patents that showcase his innovative approach to medical technology. His work primarily focuses on improving treatment methods for cancer and enhancing the efficacy of biomolecular interactions.
Latest Patents
One of Sandberg's latest patents is a trifunctional reagent for conjugation to a biomolecule. This reagent is designed as a single molecule with at least three functional parts, which includes a trifunctional cross-linking moiety coupled to an affinity ligand. This affinity ligand is capable of binding with another molecule that has an affinity for it, along with an effector agent that exerts its effect on cells, tissues, and/or humorous molecules in vivo or ex vivo. Another significant patent involves methods for targeting biomolecules to improve cancer treatment in mammals, particularly ovarian cancer. This invention utilizes intraperitoneal administration of cytotoxic medical agents or immunoconjugates, aiming to minimize the exposure of circulating cytotoxic agents in the blood.
Career Highlights
Throughout his career, Sandberg has worked with various organizations, including Mitra Medical Technology AB and the University of Washington. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Some of Sandberg's notable coworkers include Rune Nilsson and D Scott Wilbur. Their collaborative efforts have likely played a role in the development of his patents and innovations.
Conclusion
Bengt E B Sandberg's contributions to the field of biomolecular research and cancer treatment highlight his innovative spirit and dedication to improving medical technology. His patents reflect a commitment to advancing healthcare solutions, making him a significant figure in his field.